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Carriage of Helicobacter pylori strains producing more active (s1/i1) forms of VacA is strongly associated with gas-
tric adenocarcinoma. To our knowledge, we are the ﬁrst to determine effects of different polymorphic forms of VacA
on inﬂammation and metaplasia in the mouse stomach. Bacteria producing the less active s2/i2 form of VacA col-
onized mice more efﬁciently than mutants null for VacA or producing more active forms of it, providing the ﬁrst
evidence of a positive role for the minimally active s2/i2 toxin. Strains producing more active toxin forms induced
more severe and extensive metaplasia and inﬂammation in the mouse stomach than strains producing weakly active
(s2/i2) toxin. We also examined the association in humans, controlling for cagPAI status. In human gastric biopsy
specimens, the vacA i1 allele was strongly associated with precancerous intestinal metaplasia, with almost complete
absence of intestinal metaplasia in subjects infected with i2-type strains, even in a vacA s1, cagA+ background.
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Helicobacter pylori is a gram-negative microaerophilic
bacterium that infects about half the world’s population
and persists lifelong if untreated. Colonization of the
human gastric mucosa with H. pylori stimulates a
chronic inﬂammatory response with an associated life-
time risk of 10%–20% for peptic ulceration [1] and ap-
proximately 1% for gastric adenocarcinoma [2]. The
risk of disease in an infected individual is determined
by a combination of host factors, including genetic
polymorphisms [3], environmental factors such as
smoking [4], and, critically, the virulence of the infect-
ing strain. H. pylori produces multiple virulence factors,
including cytotoxin-associated gene A (CagA) and the
vacuolating cytotoxin (VacA), each of which is associat-
ed with a marked increase in the risk of disease devel-
opment (reviewed by Kusters et al [5]).
VacA, a pore-forming toxin, was named for the vac-
uolation it induces in gastric epithelial cells [6] but has
many other effects, including apoptosis induction in
gastric epithelial cells [7] and inhibition of proliferation
and IL-2 secretion by T cells [8]. CagA is translocated
into gastric epithelial cells by a type IV secretion appa-
ratus encoded within the cag pathogenicity island (cag-
PAI), where it induces morphological changes and
proinﬂammatory cytokine secretion (reviewed by
Noto and Peek [9]).
The cagPAI may be present or absent in a given
H. pylori strain. The vacA gene is present in all strains
but is polymorphic, having 2 alternative allelic variants
at its signal (s1/s2), intermediate (i1/i2), and middle
(m1/m2) regions [10, 11]. The s2 forms of VacA form
pores slowly and inefﬁciently and induce minimal vacu-
olation, if any [12].The s1 forms are more active, especial-
ly if they also have the i1 intermediate region [11]. The
midregion type affects binding to some cell lines [10, 13].
Association studies in humans examining the impor-
tance of VacA in disease are hindered by a linkage
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between cagA and vacA genotypes [14]; most vacA s1 strains
isolated are also cagA+, and most vacA s2 strains are cagA−.
We reported elsewhere that the vacA i1 allele is the best inde-
pendent predictor of gastric adenocarcinoma risk in humans,
based on a multivariate analysis including vacA s, i, and m
types and cagA [11]. Associations of i1-type vacA with peptic
ulceration, gastric atrophy, and carcinoma have since been con-
ﬁrmed by us and others [15–17]. To date, however, there is no
direct experimental evidence that these associations are causal,
in part because animal models for studying pathogenesis are
poor. Few H. pylori strains will infect mice, and the widely
used SS1 strain [18] lacks cagPAI functionality [19, 20] and ex-
presses nontoxigenic s2/i2 VacA. An alternative cagPAI+ deriv-
ative (PMSS1) [21] is also VacA s2/i2. Although many H. pylori
strains produce VacA and CagA in humans, both are absent
from other Helicobacter species naturally infecting animals
(eg, Helicobacter felis). VacA and CagA have profound effects
on mouse gastric epithelial cells, but murine T cells are resistant
to VacA-mediated inhibition [22].
Despite these limitations, several studies have examined the
role of s2/i2 VacA during infection in animal models. Early stud-
ies reported little or no difference in colonization or disease be-
tween wild-type and vacA null strains [23, 24], but Salama et al
[25] showed that carriage of vacA conferred a competitive advan-
tage over vacA null mutants and that presence of vacA facilitated
colonization of mice with lower inoculating doses. More recently,
Oertli et al [26] reported that vacA null mutants colonized mice
at reduced levels while inducing stronger T-helper 1 and T-helper
17 responses. In nature, vacA nullH. pylori strains are very rarely
found—the gene is maintained in bacterial populations—but it is
unclear why the nonvacuolating s2/i2 form is maintained so
widely or what role it might play during infection.
We aimed to characterize the role of different vacA polymor-
phic forms in H. pylori pathogenesis. Uniquely, we determined
effects of VacA polymorphisms on colonization, inﬂammation,
and precancerous changes in mice. We also showed that the
vacA i1 allele is associated with an increased risk of intestinal
metaplasia in the gastric mucosa of infected human patients.
MATERIALS AND METHODS
H. pylori Strains
The strains used in this study were SS1s1i1, SS1s1i2, SS1s2i2, and
SS1null. All strains were isogenic and constructed on the SS1
background, with vacA genotypes as indicated. All strains
were minimally passaged. Mutants were generated by natural
transformation of wild-type SS1 with plasmid pJR100 [11], con-
taining the s1/i1-encoding region of vacA from strain 60190, to
make SS1s1i1 or with plasmid pCTB2cat [10] to make SS1s1i2
and SS1s2i2. After allelic exchange by homologous recombina-
tion and chloramphenicol resistance marker rescue, the vacA al-
lele in each transformant was sequenced to conﬁrm its
genotype. The SS1s2i2 strain expresses the same VacA type as
wild-type SS1, in similar quantities (Figure 1) but also contains
the chloramphenicol resistance cassette present in the other
mutants. SS1null was produced by inserting a kanamycin resis-
tance cassette into the vacA coding sequence using plasmid
pCTB8::Km [27]. Because strains expressing s2i1 VacA are al-
most never found in human infections, an SS1s2i1 strain was
not constructed for this study.
Vacuolation Assay
RK13 cells (American Type Culture Collection CCL-37) were
maintained at 37°C and 5% carbon dioxide in Ham F12 medi-
um supplemented with 2 mmol/L L-glutamine and 10% fetal
bovine serum (Sigma-Aldrich). Bacterial water extracts were
prepared as described elsewhere [10] and applied at 75 µg/mL
to 1 × 104 cells per well in 96-well plates in the presence of
10 mmol/L ammonium chloride. After 4 hours, the extent of
vacuolation was quantiﬁed with light microscopy and expressed
as the mean proportion of vacuolated cells per ﬁeld (≥100 cells
assessed per experimental condition, 4 ﬁelds per condition, and
duplicate independent experiments).
Western Blotting
The protein concentration of each bacterial water extract was de-
termined by means of bicinchoninic acid assay (Thermo Scien-
tiﬁc) and adjusted to 750 µg/mL. Next, 7.5 µg of total protein per
lane was separated by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis, and the relative VacA content of each extract was
determined by Western blotting. All samples were tested on the
same gel and blot. VacA was labeled by using a 1:1 mixture of
rabbit polyclonal serum raised in house against VacA p33 and
p55 subunits, diluted 1:10 000, and then horseradish peroxi-
dase–conjugated goat anti-rabbit secondary antibody (Sigma),
also at 1:10 000 dilution. Equal protein loading in each lane
was conﬁrmed by Coomassie staining of duplicate gels.
Mouse Infection Study Design
All animal procedures were carried out under Home Ofﬁce pro-
ject license 40/3399, according to UK Home Ofﬁce and institu-
tional guidelines and with prior approval from the University of
Nottingham Animal Welfare and Ethical Review Body. Groups
of 6–8-week-old female C57BL/6J mice (Charles River UK)
were housed in individually ventilated cages and allowed
water and food ad libitum. Mice were infected with doses of
109 bacteria in 100 µL of Brucella broth (Difco Laboratories)
by oral gavage on 3 alternate days. The viability of each inocu-
lum was conﬁrmed by quantitative culture after dosing [28],
and no signiﬁcant differences in viability were seen between
the strains tested.
Quantitative Culture From Mouse Stomachs and Histology
After 1, 3, or 6 weeks, mice were euthanized. Stomachs were
carefully halved longitudinally along the greater and lesser
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curvatures and rinsed in sterile phosphate-buffered saline. Half
of each stomach was manually disrupted on ice in 750 µL of Iso-
Sensitest (Oxoid, Basingstoke, UK) broth/15% glycerol, serially
diluted, and plated on Galaxo Selective Supplement A plates
(blood agar base 2 (Oxoid) plates supplemented with 10% deﬁ-
brinated horse blood, 10 µg/mL vancomycin, 20 µg/mL bacitra-
cin, 4 µg/mL amphotericin B, 2.5 IU/mL polymyxin B sulfate
and 1.07 µg/mL nalidixic acid). The other half of the stomach
was formalin ﬁxed, parafﬁn embedded and sectioned, then
stained with hematoxylin-eosin or periodic acid–Schiff/Alcian
blue. The hematoxylin-eosin–stained sections were scored for
severity of inﬂammation and spasmolytic polypeptide-express-
ing metaplasia (SPEM) by the same qualiﬁed histopathologist
(P. V. K.) in a blinded manner. Sections were assigned scores
of 0 (absent), 1 (mild), 2 (moderate), or 3 (severe). Because in-
ﬂammation and SPEM were patchy in the mouse gastric muco-
sa after 1–6 weeks of infection, the length of each was measured
and normalized to the total length of corpus examined, to quan-
tify the extent of inﬂammation and SPEM for each mouse.
Human Studies
We studied patients attending the Queen’s Medical Centre, Not-
tingham, United Kingdom, between 2002 and 2012 for routine
upper gastrointestinal endoscopy, usually for investigation of
dyspepsia. Written informed consent was obtained from all pa-
tients, with approval of the Nottingham Research Ethics Com-
mittee 2 (08/H0408/195). Gastric biopsy specimens were
collected into Iso-Sensitest broth/15% glycerol for culture and
Figure 1. Expression levels and activities of VacA from SS1 mutant series. A,Water extracts (7.5 µg total protein per lane) were Western blotted for VacA
to conﬁrm the presence or absence of toxin expression and relative quantities of toxin production. WT, wild type. B, RK13 cells were incubated for 4 hours in
the presence of 75 µg/mL of the water extracts shown in A. The extent of vacuolation was quantiﬁed with light microscopy; vacuolating activity is presented
as the mean ( ± standard deviation) proportion of vacuolated cells per ﬁeld of view from ≥4 ﬁelds). C, Representative microscopic images of vacuolation.
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further biopsy specimens were formalin ﬁxed for histological
examination. We examined an unselected group of patients
for whom histological data were available and H. pylori success-
fully cultured. Samples from patients who had taken nonsteroi-
dal anti-inﬂammatory drugs or antibiotics in the 2 weeks before
endoscopy were excluded from the study. The population was
52% male with an age range of 17–82 years (median, 55 years).
A qualiﬁed histopathologist (A. A. M. Z.), who was blinded
to other data, used the updated Sydney scoring system [29]
to score colonization density, inﬂammation, activity, atrophy,
and intestinal metaplasia in biopsy sections. The H. pylori
strains cultured from biopsy specimens were typed for
vacA by polymerase chain reaction (PCR), according to
established methods [11, 30, 31]. PCR typing for presence or
absence of the cagA gene was carried out using primers A22F
(5′-TTCATGGGCGTGTTTGATG) and A23R (5′-ATAATCT
TTGAGAGTGTAGCTC) [32] alongside reference strains
60190 (cagA+) and Tx30a (cagA−). Specimens that were nega-
tive for cagA at PCR were conﬁrmed serologically with use of
a CagA immunoglobulin G enzyme-linked immunosorbent
assay kit (Genesis Diagnostics).
Statistical Analysis
GraphPad Prism software (version 5; GraphPad) was used for
all statistical analyses. The tests used are indicated in the ﬁgure
legends.
RESULTS
Production and Characterization of Isogenic vacA Mutants in
the SS1 Strain Background
We engineered wild-type SS1 (SS1WT, naturally vacA s2/i2/m2
and unable to translocate CagA) [18, 33–35] to produce s1/i1
(SS1s1i1) or s1/i2 (SS1s1i2) VacA, using a chloramphenicol resis-
tance cassette to recover transformants. To control for the pos-
sibility that this engineering adversely affected the strain, we
also constructed a strain producing wild-type s2/i2 VacA
using the same cassette (SS1s2i2). Finally, we disrupted the
vacA gene in SS1WT to produce SS1null mutants.
SS1WT, SS1s1i1, SS1s1i2, and SS1s2i2 had similar growth rates
and adherence to AGS and RK13 cells (data not shown) and ex-
pressed similar quantities of VacA (Figure 1A). As expected,
water extracts prepared from SS1s1i1 caused extensive vacuola-
tion of RK13 cells, whereas those from SS1s1i2, SS1s2i2, and
SS1null caused minimal or no vacuolation (Figure 1B and 1C).
Promotion of Gastric Colonization in Mice by Nontoxigenic
s2/i2 VacA
Consistent with the ﬁndings of Salama et al [25] and Oertli et al
[26], in our hands SS1null was impaired for colonization in 5 in-
dependent experiments. SS1null mutant 1 was recovered from
only 1 of 19 mice 3 weeks after infection, and mutant 2 was
recovered from 3 of 7 (combined data from 26 mice inoculated
with SS1null are shown in Figure 2) . SS1s2i2 colonized mice read-
ily (93% of mice successfully infected), with gastric colonization
densities similar to those we usually detect for SS1WT. Given
that the null mutants had reduced colonization rates, indicating
a role for VacA, we were surprised to ﬁnd that the SS1s1i1 and
SS1s1i2 strains were also impaired for colonization (Figure 2).
Expression of type s1/i1 or s1/i2 VacA signiﬁcantly reduced
both the proportion of successful infections (24% for SS1s1i1
Figure 2. Expression of s2/i2 vacA promotes Helicobacter pylori coloniza-
tion in mice. Mice were infected with SS1 expressing s1/i1, s1/i2, or s2/i2 or
null for vacA. After 3 weeks, gastric colonization densities were determined
by quantitative culture. Data shown for each group are combined from a
minimum of 4 independent experiments. Data for vacA null group are com-
bined from 2 independently produced vacA null mutants. A, Proportion of
mice from which H. pylori was successfully recovered 3 weeks after inoc-
ulation. B, Colonization densities in the stomachs of infected mice. SS1s1i1
and SS1s1i2 colonized mice to 7.4-fold and 7.3-fold lower mean densities,
respectively, than SS1s2i2. Of 26 mice inoculated with SS1null, bacteria
were recovered from only 4 mice after 3 weeks, and the colonization den-
sities were highly variable. Data were analyzed by means of 1-way analysis
of variance with Tukey posttest. Horizontal lines indicate mean values for
each experimental group; CFU, colony-forming units.
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and 15% for SS1s1i2) and gastric colonization densities in suc-
cessfully infected mice, compared with expression of s2/i2-
type VacA (7.4-fold for SS1s1i1 [P < .01] and 7.3-fold for
SS1s1i2 [P = .08]). This indicates that expression of nontoxigenic
s2/i2 VacA confers an advantage forH. pylori over s1/i2 or s1/i1
VacA.
Induction of Inﬂammation and SPEM by Expression of
s1/i1-Type vs s2/i2-Type VacA in the SS1 Mouse Model
Gastric tissue sections from inoculated mice were stained with
hematoxylin-eosin and scored for intensity of inﬂammation
and SPEM. In the gastric mucosa after 3 weeks of infection,
areas of inﬂammation and SPEM were visible and in some
cases extensive (Figure 3) but were interspersed with patches
of normal-appearing mucosa. Consistent with previous reports
[36], SPEM in infected mice was characterized by the loss of
specialized gland cells and expansion of metaplastic cells with
abundant, “foamy” mucin-ﬁlled cytoplasm that stained pur-
ple/blue with periodic acid–Schiff/Alcian blue (Figure 3).
There were no correlations between colonization density and
severity or extent of inﬂammation or SPEM. However, 3 weeks
after inoculation, SPEM was signiﬁcantly more extensive in
mice given SS1s1i1 than in those given SS1s2i2 (P < .05), and
throughout the study there were trends to more severe and ex-
tensive gastric inﬂammation and SPEM in mice given SS1s1i1
than in those given SS1s1i2 or SS1s2i2 (Figure 4), ﬁndings further
conﬁrmed in the time course studies below.
To determine whether inﬂammation and SPEM would rap-
idly resolve after an acute phase immediately after inoculation,
or progress over time, we conducted time course infection stud-
ies for SS1s1i1 and SS1s2i2, with histological analysis 1, 3, and 6
weeks after inoculation. Inﬂammation and SPEM became in-
creasingly extensive over time, and the proportion of mice in
each group with moderate to severe inﬂammation and SPEM
also increased (Figure 5). Although this experiment was to de-
termine time courses of individual mutants, experiments were
performed concurrently, so further comparisons between mu-
tants were possible. Mice given SS1s1i1 had more severe
(P = .07) and extensive (P = .08) SPEM than those given
SS1s2i2 at 1 week after dosing, but inﬂammation was minimal
in both groups at this early time point. SS1s1i1 and SS1s2i2 in-
duced similar levels of inﬂammation and SPEM after 3 and 6
weeks, even though SS1s1i1 colonized only 1 mouse to detectable
levels (SS1s2i2 colonized all mice at high levels); thus, the
amount of inﬂammation and SPEM per viable bacterium was
much higher in the SS1s1i1-infected animals.
vacA i Region Type and Risk of Intestinal Metaplasia in Humans
Given the impact of vacA polymorphisms on gastric histopa-
thology in mice and the strong association between carriage
of i1-type strains and gastric adenocarcinoma in human popu-
lations, we went on to examine associations of vacA type with
intestinal metaplasia in H. pylori–infected patients.
H. pylori was successfully isolated by culture from gastric bi-
opsy specimens taken from 85 patients. Of these, 62% of strains
(n = 53) were vacA s1/i1 type, 27% (n = 23) were s1/i2, and 11%
(n = 9) were s2/i2. Consistent with previous reports, no s2/i1-
type strains were isolated from this cohort. Because carriage
of s2-type strains was rare, we were unable to compare s1 and
Figure 3. Infection with SS1s1i1 induces spasmolytic polypeptide-
expressing metaplasia (SPEM) and inﬂammation in mouse gastric mucosa.
A, Hematoxylin-eosin (HE)–stained gastric sections from a mouse 3 weeks
after dosing with SS1s1i1 in Brucella broth showing inﬂammatory inﬁltrate
(asterisk), loss of specialized gland cells, and marked expansion of cells
with foamy cytoplasm indicative of mucinous metaplasia (arrows). B,
Periodic acid–Schiff (PAS)/Alcian blue staining on gastric sections from
SS1s1i1-dosed mice after 3 weeks of infection conﬁrmed the replacement
of specialized gland cells with mucin-containing cells (blue-staining acid
mucin and purple-staining neutral mucin), consistent with SPEM [36]. C,
Sections from a mouse dosed with Brucella broth only. D, SPEM was ab-
sent 3 weeks after dosing with Brucella broth. Panels A and B are repre-
sentative of SPEM and inﬂammation scores of 3 (severe); panels C and D
representative of inﬂammation scores of 0 (absent). Bar represents 200 µm
for all panels.
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s2 effects in this study but could directly compare i1 and i2 ef-
fects in the s1 background.
There were no differences in levels of inﬂammation, activity,
atrophy, or colonization density between patients infected with
vacA i1-type or i2-type strains (data not shown), but a marked
difference was seen in levels of intestinal metaplasia (Figure 6).
Intestinal metaplasia was detected in only 1 of 32 patients (3%)
infected with an i2-type strain, with only mild severity, but
mild, moderate, or severe intestinal metaplasia were seen in
15 of 53 patients (28%) infected with an i1-type strain (P < .01;
Figure 6A–C).
Because vacA i1-type strains also tend to be vacA s1 type and
cagA positive, we ﬁrst excluded vacA s2-type strains (Figure 6D)
and then vacA s1-type, cagA− strains (Figure 6E ) from our anal-
ysis. The association of intestinal metaplasia with vacA i1 type
remained when s2-type strains were excluded (28% of patients
with s1/i1 strains had intestinal metaplasia vs 4% with s1/i2
strains; P < .05). When all cagA− strains were also excluded,
26% of patients (11 of 43) with i1 strains had intestinal metapla-
sia, compared with only 8% (1 of 13) with i2 strains. There was
also a trend toward an association between the vacA i1 allele
and intestinal metaplasia in patients infected with vacA s1,
cagA− strains (P = .10; Figure 6F ), although consistent with
other reports, such strains were uncommon in our patient cohort.
DISCUSSION
Although several studies using vacA null mutant strains in an-
imal models have aimed to clarify the contribution of the VacA
toxin to pathogenesis, ﬁndings have been mixed [23–26]. The
consensus now emerging is that VacA does confer a coloniza-
tion advantage in mice, but in humans nearly all strains are
vacA positive, and the critical determinant of disease risk is
the type of toxin expressed, rather than its presence or absence.
We used strains with VacA types found to occur naturally in
human infection but on an isogenic background to remove all
other strain differences. We selected a functionally cagPAI-null
background to remove any confounding or masking effects, be-
cause CagA is known to cause inﬂammation in animal models
[21, 37].
Consistent with ﬁndings in other SS1-mouse studies, we
found that our SS1s2i2 strain colonized C57BL/6J mice readily.
Our SS1null mutants had reduced colonization rates, consistent
with the impaired colonization reported elsewhere for vacA-null
Figure 4. Expression of s1/i1-type vacA induces more severe gastric inﬂammation and spasmolytic polypeptide-expressing metaplasia (SPEM) in the
C57BL/6J mouse SS1 Helicobacter pylori infection model. Groups of 5–6 mice per study were inoculated with SS1 expressing s1/i1-, s1/i2-, or s2/i2-type
VacA in Brucella broth. After 3 weeks, the severity of inﬂammation and SPEM in stomach sections were quantiﬁed histologically using an adapted Sydney
scoring system. Inﬂammation and SPEM extent were quantiﬁed by measuring the length of inﬂamed or metaplastic corpus and expressing each as a pro-
portion of the total corpus length examined. Data presented are combined from 2 independent studies; in each study, all 3 groups were examined in parallel.
Horizontal lines indicate median values for each group. P values were calculated with 2-tailed Mann-Whitney tests.
6 • JID • Winter et al
 at N
ottingham
 Trent U
niversity on June 18, 2014
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
SS1 [25] and PMSS1 [26]. We also found that strains producing
s1/i1 and s1/i2 VacA had reduced colonization success rates and
densities. This is the ﬁrst evidence, to our knowledge, of a pos-
itive role for the less-active s2/i2 form of VacA compared with
the s1/i2 or s1/i1 forms.
Many human studies have shown associations between
strains with active forms of VacA and disease, and the best of
these have controlled for other virulence factors, including cag-
PAI status. However, doubts about the direct importance of
VacA in disease have remained, in part because animal model
experiments have proved difﬁcult and the effects of VacA de-
scribed in these models have largely been conﬁned to coloniza-
tion differences. By introducing isogenic hybrid forms of VacA
in a mouse-colonizing H. pylori strain with a cag-null back-
ground, we have demonstrated independent effects of VacA
on induction of inﬂammation and metaplasia, showing that
the s1/i1 type of VacA is the most pathogenic, consistent with
known disease associations in humans.
Mice in the studies presented in Figures 4 and 5 were from
the same supplier, housed in the same facility, and treated
identically but were from multiple batches, dosed on separate
occasions. Although colonization densities in infected mice
were consistent within each group across 4–5 independent ex-
periments per group (Figure 2), levels of inﬂammation and
SPEM were quite variable. We suggest that batch variation, per-
haps in non–H. pylori gastric ﬂora, may contribute to the histo-
logical parameters measured. However, SS1s1i1 consistently
induced more severe and extensive inﬂammation and SPEM
than SS1s2i2, despite colonizing poorly. It is possible that induc-
tion of inﬂammation and damage by the strains producing
more active VacA contributed to the reduced colonization den-
sities achieved by these strains. However, we did not see any sig-
niﬁcant correlation between colonization density and gastric
pathology in this study.
H. pylori is not a natural colonizer of mice, and there are im-
munological and physiological differences between mice and
humans. Thus, it is important to show relevance in a human
population. The results in our UK population were more dra-
matic than we expected, given the relatively modest differences
seen in mice: intestinal metaplasia was found in many patients
Figure 5. Inoculation of C57BL/6J mice with SS1s1i1 or SS1s2i2 induces progressive inﬂammation and spasmolytic polypeptide-expressing metaplasia
(SPEM). Groups of 5–10 mice were infected with SS1 expressing s2/i2 (A) or s1/i1 (B) type VacA in Brucella broth. After 1, 3, or 6 weeks, stomach sections
were histologically scored using an adaptation of the Sydney system, and inﬂammation and SPEM extent expressed as percentage of total corpus length
examined with scores of 1 (mild) to 3 (severe). The severity and extent of inﬂammation and SPEM increased progressively with infection time for both
SS1s2i2 and SS1s1i1. Horizontal lines indicate median values for each group.
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infected with vacA s1/i1 strains, regardless of cag status, but in
only 1 patient who did not have an s1/i1 strain isolated, and in
that patient the ﬁndings were grade 1 only (mild). This raises
several interesting issues. First, because s2/i1 strains are rarely
found naturally, it might only be necessary to type the i region
to identify metaplasia-associated strains. Second, it is not sur-
prising that many s1/i1 strains were not associated with meta-
plasia; we regard these as metaplasia-inducing strains, but many
other factors, including age, length of infection, environmental
cofactors, and host genetics, are likely to determine whether an
individual will develop metaplasia or will have developed it by
the time of the study. Furthermore, metaplasia is a patchy phe-
nomenon in the human stomach, and single-pinch biopsy spec-
imens may not detect it reliably.
There are some interesting differences between our ﬁndings
in mice and humans. Only in mice were there associations be-
tween vacA type and inﬂammation. This may be because cag is
the dominant driver of inﬂammation in humans, and in our
mice, to avoid confounding effects, we used a cag-null strain
background. However, in humans we saw a strong association
between vacA i1 strains and metaplasia despite seeing no diffe-
rence in levels of gastric inﬂammation. This may imply that
VacA is driving metaplasia through a different mechanism,
for example, through a direct toxic effect on the gastric epithe-
lium. However, there are alternative explanations; for example,
there may have been different levels of inﬂammation earlier in
life, even in childhood, that are no longer evident in long-
established infection. A second interesting difference is that
Figure 6. Carriage of vacA i1-type strains is associated with increased incidence of intestinal metaplasia in the human stomach. The severity of intes-
tinal metaplasia in gastric biopsy specimens from patients infected with vacA s2i2- (n = 9), s1i2- (n = 23), or s1i1- (n = 53) type Helicobacter pylori strains
was scored in a blinded fashion by a qualiﬁed histopathologist. Intestinal metaplasia was seen in a single patient infected with an i2-type strain (3%) but
was present in 28% of patients infected only with i1-type strains (A–C). The association between vacA i type and intestinal metaplasia remained when only
patients infected with vacA s1-type strains (D) were included, and similar trends were observed in groups infected with vacA s1-type, cagA+ (E ) and vacA
s1-type, cagA− strains (F ). Data were analyzed using a Kruskal-Wallis test with Dunn posttest (A) and Fisher exact tests (B–F ).
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even quite severe metaplasia was sometimes found in mice in-
fected with vacA s2/i2 or s1/i2 strains. In humans, only s1/i1
strains were associated with moderate or severe metaplasia.
Human and mouseH. pylori infections are very different, and
it would be surprising if the same level of disease was observed
in both. However, because non-i1 strains can cause metaplasia
in mice, it is important to study the association of such strains
with metaplasia in humans in larger and different populations.
This may be clinically important: if vacA i2 strains are rarely as-
sociated with metaplasia and cancer in human populations,
there is no need to treat them to prevent cancer.
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